Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, L…

Recall date

December 18, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0250-2026

FDA classification

Class II

Brand / firm

Imprimis NJOF, LLC

Sold / distributed

U.S Nationwide

Why it was recalled

Presence of particulate matter - Glass like particles.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.